College
Rowan-Virtua School of Osteopathic Medicine
Keywords
infectious disease, babesia, babesiosis, borrelia, neutropenic fever, oncology, tick-born illnesses, lyme disease, neutropenia, hematology
Date of Presentation
5-1-2025 12:00 AM
Poster Abstract
The advent of immunomodulatory therapies and their ever-expanding number of treatment indications necessitates the understanding of their associated complications. Neutropenic fever serves as an example of these complications often encountered in clinical practice. Although neutropenic fever can result from virtually any pathogen, episodes of the syndrome secondary to tick-borne illness remain relatively undocumented in the scientific literature. In the case presented, a 77-year-old female with a pertinent past medical history of smoldering IgG multiple myeloma on active immunosuppressive therapy presented with a first-time episode of neutropenic fever likely secondary to tick-borne illness. Through this overview of a broader report, attention is drawn to an additional source pathogen for neutropenic fever and its management, thus expanding upon clinician understanding of this all-too-common complication of immunosuppression.
Disciplines
Bacterial Infections and Mycoses | Hematology | Hemic and Lymphatic Diseases | Infectious Disease | Medicine and Health Sciences | Neoplasms | Oncology | Pathological Conditions, Signs and Symptoms
Included in
Bacterial Infections and Mycoses Commons, Hematology Commons, Hemic and Lymphatic Diseases Commons, Infectious Disease Commons, Neoplasms Commons, Oncology Commons, Pathological Conditions, Signs and Symptoms Commons
A Ticking Time Bomb: An Overview of a Case Report of Neutropenic Fever Secondary to Tick-Borne Illness
The advent of immunomodulatory therapies and their ever-expanding number of treatment indications necessitates the understanding of their associated complications. Neutropenic fever serves as an example of these complications often encountered in clinical practice. Although neutropenic fever can result from virtually any pathogen, episodes of the syndrome secondary to tick-borne illness remain relatively undocumented in the scientific literature. In the case presented, a 77-year-old female with a pertinent past medical history of smoldering IgG multiple myeloma on active immunosuppressive therapy presented with a first-time episode of neutropenic fever likely secondary to tick-borne illness. Through this overview of a broader report, attention is drawn to an additional source pathogen for neutropenic fever and its management, thus expanding upon clinician understanding of this all-too-common complication of immunosuppression.
